BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 37936209)

  • 1. Induced pluripotent stem cells derived from patients carrying mitochondrial mutations exhibit altered bioenergetics and aberrant differentiation potential.
    Meshrkey F; Scheulin KM; Littlejohn CM; Stabach J; Saikia B; Thorat V; Huang Y; LaFramboise T; Lesnefsky EJ; Rao RR; West FD; Iyer S
    Stem Cell Res Ther; 2023 Nov; 14(1):320. PubMed ID: 37936209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
    Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
    Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the genic and metabolic characteristics of induced pluripotent stem cells from polycystic ovary syndrome women.
    Min Z; Gao Q; Zhen X; Fan Y; Tan T; Li R; Zhao Y; Yu Y
    Stem Cell Res Ther; 2018 Aug; 9(1):210. PubMed ID: 30092830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
    Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
    Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-derived induced pluripotent stem cells with a
    Zhang H; Wu LZ; Liu ZY; Jin ZB
    World J Stem Cells; 2024 May; 16(5):512-524. PubMed ID: 38817331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes.
    Haile Y; Nakhaei-Nejad M; Boakye PA; Baker G; Smith PA; Murray AG; Giuliani F; Jahroudi N
    PLoS One; 2015; 10(3):e0119617. PubMed ID: 25789622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niemann-Pick type C1 patient-specific induced pluripotent stem cells display disease specific hallmarks.
    Trilck M; Hübner R; Seibler P; Klein C; Rolfs A; Frech MJ
    Orphanet J Rare Dis; 2013 Sep; 8():144. PubMed ID: 24044630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human induced pluripotent stem cells from two azoospermic patients with Klinefelter syndrome show similar X chromosome inactivation behavior to female pluripotent stem cells.
    Panula S; Kurek M; Kumar P; Albalushi H; Padrell Sánchez S; Damdimopoulou P; Olofsson JI; Hovatta O; Lanner F; Stukenborg JB
    Hum Reprod; 2019 Nov; 34(11):2297-2310. PubMed ID: 31743397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro erythrocyte production using human-induced pluripotent stem cells: determining the best hematopoietic stem cell sources.
    Cho YK; Kim HK; Kwon SS; Jeon SH; Cheong JW; Nam KT; Kim HS; Kim S; Kim HO
    Stem Cell Res Ther; 2023 Apr; 14(1):106. PubMed ID: 37101221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of a novel xeno-free culture medium for human-induced pluripotent stem cells.
    Hua Y; Yoshimochi K; Li J; Takekita K; Shimotsuma M; Li L; Qu X; Zhang J; Sawa Y; Liu L; Miyagawa S
    Stem Cell Res Ther; 2022 Jun; 13(1):223. PubMed ID: 35658933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass cytometry-based single-cell analysis of human stem cell reprogramming uncovers differential regulation of specific pluripotency markers.
    Im I; Son YS; Jung KB; Kang I; Teh BE; Lee KB; Son MY; Kim J
    J Biol Chem; 2019 Dec; 294(49):18547-18556. PubMed ID: 31570522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential Hematopoietic Differentiation in Induced Pluripotent Stem Cells Derived From Human Umbilical Cord Arterial Endothelial Cells.
    Pei H; Li H; Xu L; Zhang B; Zhang H; Jia Y; Liang L; Xie X; Fan Z; Yang Z; Wang X; Song F; He L; Yue W; Pei X
    Arterioscler Thromb Vasc Biol; 2023 May; 43(5):697-712. PubMed ID: 36951064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of mitochondrial morphologies in human induced pluripotent stem cells for Leigh syndrome.
    Meshrkey F; Cabrera Ayuso A; Rao RR; Iyer S
    Stem Cell Res; 2021 Dec; 57():102572. PubMed ID: 34662843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural underlying mtDNA heteroplasmy as a potential source of intra-person hiPSC variability.
    Perales-Clemente E; Cook AN; Evans JM; Roellinger S; Secreto F; Emmanuele V; Oglesbee D; Mootha VK; Hirano M; Schon EA; Terzic A; Nelson TJ
    EMBO J; 2016 Sep; 35(18):1979-90. PubMed ID: 27436875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TALEN-mediated generation and genetic correction of disease-specific human induced pluripotent stem cells.
    Ramalingam S; Annaluru N; Kandavelou K; Chandrasegaran S
    Curr Gene Ther; 2014; 14(6):461-72. PubMed ID: 25245091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scalable stirred suspension culture for the generation of billions of human induced pluripotent stem cells using single-use bioreactors.
    Kwok CK; Ueda Y; Kadari A; Günther K; Ergün S; Heron A; Schnitzler AC; Rook M; Edenhofer F
    J Tissue Eng Regen Med; 2018 Feb; 12(2):e1076-e1087. PubMed ID: 28382727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.